Jean-Jacques Mourad

The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target

Jean-Jacques Mourad, J. Mourad, 2008, Vascular health and risk management.

Aortic pulse pressure and extent of coronary artery disease in percutaneous transluminal coronary angioplasty candidates.

J. Blacher, M. Safar, A. Dibié, 2002, American journal of hypertension.

From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century

G. Bakris, J. Blacher, M. Safar, 2016, The Lancet.

Interaction between RAAS inhibitors and ACE2 in the context of COVID-19

B. Lévy, Jean-Jacques Mourad, J. Mourad, 2020, Nature Reviews Cardiology.

Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus

Eric Vicaut, E. Vicaut, E. Schiffrin, 2008, Circulation.